Given the momentum in the stock market and come back of the pharma space on lower valuation and Covid led demand, healthcare funds have been giving higher than benchmark return of 67 percent.
While the theme we are taking about is pharma, is a niche space and needs investors' know-how. Such thematic funds or niche domains amid the stock market boom attracted the highest inflow in the month of October.
Now talking about the fund:
It is DSP Healthcare Fund-Regular Plan-Growth-the benchmark is BSE Healthcare Sensex TRI. While the benchmark return has been of 50 percent, the fund gave returns of a huge 67 percent.
Expense ratio of the fund is a huge at around 2 percent.
And the fund's total assets under management is Rs. 890.49 crore.
SIP 1-year returns with an investment of Rs. 1000 on an annualized and absolute basis have been of 79.88 and 39.58 percent, respectively.
Major allocation is in mid-cap space with constituents as IPCA Labs, Cipla, Dr. Reddy's, Divis, Apollo Hospitals etc.
And further the peers of the fund are Mirae Asset Healthcare Fund, ICICI Prudential Pharma Healthcare and Diagnostics, UTI Healthcare Growth among others.